AKT1 and esophageal cancer: Moreover, the alpha7 nAChR antagonist α-Bungarotoxin substantially impaired nicotine-induced Akt activation, FOXO1 inhibition, and OTUD3 downregulation in esophageal cancer cells (Supplementary Fig. 1h, i).